87 related articles for article (PubMed ID: 29595211)
1. Correction: A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways.
Jiang K; Chi T; Li T; Zheng G; Fan L; Liu Y; Chen X; Chen S; Jia L; Shao JW
Nanoscale; 2018 Mar; 10(13):6212-6213. PubMed ID: 29595211
[TBL] [Abstract][Full Text] [Related]
2. A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways.
Jiang K; Chi T; Li T; Zheng G; Fan L; Liu Y; Chen X; Chen S; Jia L; Shao J
Nanoscale; 2017 Jul; 9(27):9428-9439. PubMed ID: 28660943
[TBL] [Abstract][Full Text] [Related]
3. A novel co-drug of aspirin and ursolic acid interrupts adhesion, invasion and migration of cancer cells to vascular endothelium via regulating EMT and EGFR-mediated signaling pathways: multiple targets for cancer metastasis prevention and treatment.
Tang Q; Liu Y; Li T; Yang X; Zheng G; Chen H; Jia L; Shao J
Oncotarget; 2016 Nov; 7(45):73114-73129. PubMed ID: 27683033
[TBL] [Abstract][Full Text] [Related]
4. A Smart pH-responsive Nano-Carrier as a Drug Delivery System: A hybrid system comprised of mesoporous nanosilica MCM-41 (as a nano-container) & a pH-sensitive polymer (as smart reversible gatekeepers): Preparation, characterization and in vitro release studies of an anti-cancer drug.
Abbaszad Rafi A; Mahkam M; Davaran S; Hamishehkar H
Eur J Pharm Sci; 2016 Oct; 93():64-73. PubMed ID: 27497878
[TBL] [Abstract][Full Text] [Related]
5. Dual pH/redox responsive and CD44 receptor targeting hybrid nano-chrysalis based on new oligosaccharides of hyaluronan conjugates.
Chen D; Dong X; Qi M; Song X; Sun J
Carbohydr Polym; 2017 Feb; 157():1272-1280. PubMed ID: 27987832
[TBL] [Abstract][Full Text] [Related]
6. pH-responsive nanoreservoirs based on hyaluronic acid end-capped mesoporous silica nanoparticles for targeted drug delivery.
Chen C; Sun W; Wang X; Wang Y; Wang P
Int J Biol Macromol; 2018 May; 111():1106-1115. PubMed ID: 29357289
[TBL] [Abstract][Full Text] [Related]
7. Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling.
Yeh CT; Wu CH; Yen GC
Mol Nutr Food Res; 2010 Sep; 54(9):1285-95. PubMed ID: 20352621
[TBL] [Abstract][Full Text] [Related]
8. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
9. MMP-Responsive 'Smart' Drug Delivery and Tumor Targeting.
Yao Q; Kou L; Tu Y; Zhu L
Trends Pharmacol Sci; 2018 Aug; 39(8):766-781. PubMed ID: 30032745
[TBL] [Abstract][Full Text] [Related]
10. Self-assembled pH-responsive hyaluronic acid-g-poly((L)-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin.
Qiu L; Li Z; Qiao M; Long M; Wang M; Zhang X; Tian C; Chen D
Acta Biomater; 2014 May; 10(5):2024-35. PubMed ID: 24365705
[TBL] [Abstract][Full Text] [Related]
11. Design of novel multifunctional targeting nano-carrier drug delivery system based on CD44 receptor and tumor microenvironment pH condition.
Chen D; Lian S; Sun J; Liu Z; Zhao F; Jiang Y; Gao M; Sun K; Liu W; Fu F
Drug Deliv; 2016; 23(3):808-13. PubMed ID: 24892632
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of a Block Copolymer Exhibiting Cell-Responsive Phytochemical Release for Cancer Therapy.
Padmavathy N; Das Ghosh L; Meka SRK; Chatterjee K
ACS Appl Mater Interfaces; 2018 Jul; 10(26):21816-21824. PubMed ID: 29877694
[TBL] [Abstract][Full Text] [Related]
13. Oxaliplatin-chitosan nanoparticles induced intrinsic apoptotic signaling pathway: a "smart" drug delivery system to breast cancer cell therapy.
Vivek R; Thangam R; Nipunbabu V; Ponraj T; Kannan S
Int J Biol Macromol; 2014 Apr; 65():289-97. PubMed ID: 24472507
[TBL] [Abstract][Full Text] [Related]
14. DEVELOPMENT AND CHARACTERIZATION OF SMART DRUG DELIVERY SYSTEM.
Tulain UR; Ahmad M; Rashid A; Iqbal FM
Acta Pol Pharm; 2016 Jul; 73(4):1009-1022. PubMed ID: 29648727
[TBL] [Abstract][Full Text] [Related]
15. Advances in the Anticancer Value of the Ursolic Acid Through Nanodelivery.
Manayi A; Nikan M; Nobakht-Haghighi N; Abdollahi M
Curr Med Chem; 2018; 25(37):4866-4875. PubMed ID: 28707589
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis-induced effects of extract from Artemisia annua Linné by modulating PTEN/p53/PDK1/Akt/ signal pathways through PTEN/p53-independent manner in HCT116 colon cancer cells.
Kim EJ; Kim GT; Kim BM; Lim EG; Kim SY; Kim YM
BMC Complement Altern Med; 2017 Apr; 17(1):236. PubMed ID: 28454566
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex.
Zhao R; Li T; Zheng G; Jiang K; Fan L; Shao J
Biomaterials; 2017 Oct; 143():1-16. PubMed ID: 28755539
[TBL] [Abstract][Full Text] [Related]
18. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.
Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S
Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
[TBL] [Abstract][Full Text] [Related]
20. Ursolic acid attenuates diabetic mesangial cell injury through the up-regulation of autophagy via miRNA-21/PTEN/Akt/mTOR suppression.
Lu X; Fan Q; Xu L; Li L; Yue Y; Xu Y; Su Y; Zhang D; Wang L
PLoS One; 2015; 10(2):e0117400. PubMed ID: 25689721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]